Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_assertion type Assertion NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_head.
- NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_assertion wasGeneratedBy ECO_0000203 NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_provenance.
- NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_assertion wasDerivedFrom befree-20150227 NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_provenance.
- NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_assertion SIO_000772 15890247 NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_provenance.
- NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_assertion evidence source_evidence_literature NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_provenance.
- NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_assertion description "[Statistical analysis revealed that (i) reduced expression of hMLH1 and hMSH2 seemed to confer advantage for the progression of breast tumors to more advanced stages; (ii) attenuated expression of hMLH1 correlated with history of chemotherapy, but not with age, menopause, or the status of PR and ER; (iii) hypermethylation of the hMLH1 promoter was linked with clinical stage and lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617361.RABNcn2lZzFpNaaqyCw-7rnUtMfLA8dTedxYw6S_LoPUA130_provenance.